Payments to Acquire Property, Plant, and Equipment of POINT Biopharma Global Inc. from 31 Dec 2020 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
POINT Biopharma Global Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2020 to 31 Mar 2023.
  • POINT Biopharma Global Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2023 was $3,524,767, a 275% increase year-over-year.
  • POINT Biopharma Global Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $12,766,522, a 45% increase from 2021.
  • POINT Biopharma Global Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $8,802,182, a 10% decline from 2020.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

POINT Biopharma Global Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $3,524,767 +$2,583,836 +275% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q1 2022 $940,931 +$754,130 +404% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $186,801 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1

POINT Biopharma Global Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $12,766,522 +$3,964,340 +45% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2023 2022 FY
2021 $8,802,182 -$995,218 -10% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
2020 $9,797,400 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.